AMSTERDAM — A novel molecule that directly targets inflammation in diabetic nephropathy is safe, well-tolerated, and has significant effects that last for at least 12 weeks after discontinuation ...

Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers. In a study comparing diabetic mice treated with chromium picolinate ...

Bethesda, Md. (September 22, 2010) – Taking chromium picolinate may help lessen inflammation associated with diabetic nephropathy (kidney disease), say researchers at the Medical College of ...

Thiazolidinediones are synthetic agonists of peroxisome proliferator-activated receptors that have shown promise inin vitroand animal models of nephropathy. Encouraging early-stage data have also ...

Inflammation and oxidative stress are relevant factors in the pathogenesis of diabetic nephropathy (DN). Glomerulosclerosis, which is associated with a high amount of coagulating factors, is a ...

Inversago Pharma presents preclinical data on INV-202 in Diabetic Nephropathy at ERA 2022 ... INV-202 reduced glomerular injury, renal fibrosis and injury to proximal tubular epithelial ...